A PHASE I/II DOSE FINDING AND EFFICACY STUDY OF THE TUMOUR TARGETING HUMAN 131I-L19SIP MONOCLONAL ANTIBODY IN PATIENTS WITH CANCER

Update Il y a 4 ans
Reference: EUCTR2007-007241-12

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Phase I: - Determination of maximum tolerated dose and recommended dose Phase II: - Investigation of the antitumor activity at the recommended dose in cancer patients (objective response rate)


Inclusion criteria

  • Cancer

Links